Link to article on investing.com: https://www.investing.com/analysis/why-investors-should-track-the-prescription-drug-user-fee-act-200583708
Summary:
DUFA dates and content are essential for portfolio managers of healthcare stocks. A single positive or negative announcement from the US Food and Drug Administration (FDA) can send shares of a biotech firm soaring or turn a hot name quickly into a bear market. Among the dozens of corporate event data points provided to our customers, Wall Street Horizon gathers PDUFA dates and content so our clients stay in the know.
Recent Content
-
Mid-Q2 2024 Investor Conference & Events Highlights Update
-
CEO Uncertainty Remains High Even As Q1 Earnings Season Ends Better-than-Expected
-
Tabb Forum: Spin-Off Stocks Surprise to Start Q2 – Reviewing Recent Market-Newcomers
-
Spin-Off Stocks Surprise to Start Q2 - Reviewing Recent Market-Newcomers
-
MoneyFM: US Markets Wrap: Increase in Wall Street analysts’ Q2 S&P 500 earnings estimates
-
The Final Peak Week of the Q1 Season Begins Just As Earnings Hit Their Stride
-
The Globe and Mail: The Final Peak Week of the Q1 Season Begins
-
Solar Stocks, Berkshire, and the latest Costco Craze
-
Big Tech Earnings Beats Stymie Q2 Sell-Off
-
Volatility Watch: Eyeing a Pair of Blue Chips with Unusual Earnings Dates in the Heart of the Reporting Season